Bromide

Bromide

SCHEMBL3469640

CCCC[n+]1cc[nH]c1.[Br-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 2/20 0.42
CHRM1 known ✓ P11229 2/20 0.42
ACHE known ✓ P22303 2/20 0.42
CHRM4 known ✓ P08173 1/20 0.42
CHRM5 known ✓ P08912 1/20 0.42
CHRM3 known ✓ P20309 1/20 0.42
OPRM1 known ✓ P35372 1/20 0.39
KMT2A Q03164 5/20 0.42
HSP90AA1 P07900 4/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
HTT P42858 4/20 0.42
RAD52 P43351 3/20 0.42
ADRA2A P08913 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
LMNA P02545 2/20 0.42
EGFR P00533 1/20 0.42
PLA2G1B P04054 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL319304 0.98
Iodide SCHEMBL1816327 0.96 SMN1; SMN2 (0.41) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Iodide SCHEMBL1226159 0.96 SMN1; SMN2 (0.41) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Hydrochloric Acid SCHEMBL365125 0.96 KMT2A (0.42) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
SCHEMBL16992935 0.96 CHRM2 (0.39) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Hydrochloric Acid SCHEMBL19031751 0.94 KMT2A (0.41) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Bromide SCHEMBL14896254 0.94 KMT2A (0.50) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Bromide SCHEMBL5348732 0.92 KMT2A (0.53) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Bromide SCHEMBL22027172 0.92 KMT2A (0.53) KMT2AHSP90AA1SMN1; SMN2HTTRAD52
Bromide SCHEMBL22027189 0.92 KMT2A (0.53) KMT2AHSP90AA1SMN1; SMN2HTTRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4341315-A1 IMIDAZOLIUM-BASED POLY(IONIC LIQUID)S AND USE THEREFORE Versum Materials US, LLC (US) 2024-03-27 EP claimed
CN-113346058-A Method for preparing bimetallic sulfide and carbon compound under ionic gel system 大连理工大学 2021-09-03 CN claimed
EP-1663921-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2006-06-07 EP claimed
WO-2005026089-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2005-03-24 WO claimed
US-12325798-B1 Compositions containing lignocellulosic biomass residues, polymer composites made therefrom, and methods of making lignocellulosic biomass residues and polymer composites containing them PLANTOON TECHNOLOGIES KFT. (HU) 2025-06-10 US disclosed
US-12325799-B1 Compositions containing lignocellulosic biomass residues, polymer composites made therefrom, and methods of making lignocellulosic biomass residues and polymer composites containing them PLANTOON TECHNOLOGIES KFT. (HU) 2025-06-10 US disclosed
US-12018156-B1 Compositions containing lignocellulosic biomass residues, polymer composites made therefrom, and methods of making lignocellulosic biomass residues and polymer composites containing them PLANTOON TECHNOLOGIES KFT. (HU) 2024-06-25 US disclosed
US-12012514-B1 Compositions containing lignocellulosic biomass residues, polymer composites made therefrom, and methods of making lignocellulosic biomass residues and polymer composites containing them PLANTOON TECHNOLOGIES KFT. (HU) 2024-06-18 US disclosed
CN-112251240-B Quaternary ammonium salt ionic liquid crystal polymer with temperature control electronic switch performance and preparation method and application thereof 东北大学 2022-04-12 CN disclosed
CN-112251240-A Quaternary ammonium salt ionic liquid crystal polymer with temperature control electronic switch performance and preparation method and application thereof 东北大学 2021-01-22 CN disclosed
US-8716532-B2 One pot multicomponent synthesis of some novel hydroxy stilbene derivatives with alpha, beta-carbonyl conjugation under microwave irradiation COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2014-05-06 US disclosed
US-20120165567-A1 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2012-06-28 US disclosed
US-20120157579-A1 Azolium Ionomer Derivatives of Halogenated Polymers QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-06-21 US disclosed
WO-2012075574-A1 AZOLIUM IONOMER DERIVATIVES OF HALOGENATED POLYMERS QUEEN'S UNIVERSITY AT KINGSTON (CA) 2012-06-14 WO disclosed
WO-2010113005-A2 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165567-A1 ONE POT MULTICOMPONENT SYNTHESIS OF SOME NOVEL HYDROXY STILBENE DERIVATIVES WITH ALPHA, BETA-CARBONYL CONJUGATION UNDER MICROWAVE IRRADIATION SIK1, SIK2, HCK CHRM2 4520/4885CHRM1 3968/4885ACHE 2837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.